These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 18973685)
1. Recombinant amyloid beta-peptide production by coexpression with an affibody ligand. Macao B; Hoyer W; Sandberg A; Brorsson AC; Dobson CM; Härd T BMC Biotechnol; 2008 Oct; 8():82. PubMed ID: 18973685 [TBL] [Abstract][Full Text] [Related]
2. Engineered non-fluorescent Affibody molecules facilitate studies of the amyloid-beta (Aβ) peptide in monomeric form: low pH was found to reduce Aβ/Cu(II) binding affinity. Lindgren J; Segerfeldt P; Sholts SB; Gräslund A; Karlström AE; Wärmländer SK J Inorg Biochem; 2013 Mar; 120():18-23. PubMed ID: 23262458 [TBL] [Abstract][Full Text] [Related]
3. N-terminal engineering of amyloid-β-binding Affibody molecules yields improved chemical synthesis and higher binding affinity. Lindgren J; Wahlström A; Danielsson J; Markova N; Ekblad C; Gräslund A; Abrahmsén L; Karlström AE; Wärmländer SK Protein Sci; 2010 Dec; 19(12):2319-29. PubMed ID: 20886513 [TBL] [Abstract][Full Text] [Related]
4. Selection and characterization of Affibody ligands binding to Alzheimer amyloid beta peptides. Grönwall C; Jonsson A; Lindström S; Gunneriusson E; Ståhl S; Herne N J Biotechnol; 2007 Jan; 128(1):162-83. PubMed ID: 17088007 [TBL] [Abstract][Full Text] [Related]
5. A theoretical study on the molecular determinants of the affibody protein Z(Aβ3) bound to an amyloid β peptide. Wang X; Sun X; Kuang G; Ågren H; Tu Y Phys Chem Chem Phys; 2015 Jul; 17(26):16886-93. PubMed ID: 26060853 [TBL] [Abstract][Full Text] [Related]
6. The Arctic mutation alters helix length and type in the 11-28 beta-amyloid peptide monomer-CD, NMR and MD studies in an SDS micelle. Rodziewicz-Motowidło S; Czaplewska P; Sikorska E; Spodzieja M; Kołodziejczyk AS J Struct Biol; 2008 Nov; 164(2):199-209. PubMed ID: 18765285 [TBL] [Abstract][Full Text] [Related]
7. Protein L-isoaspartyl O-methyltransferase inhibits amyloid beta fibrillogenesis in vitro. Jung G; Ryu J; Heo J; Lee SJ; Cho JY; Hong S Pharmazie; 2011 Jul; 66(7):529-34. PubMed ID: 21812329 [TBL] [Abstract][Full Text] [Related]
8. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease? Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267 [TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils. Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812 [TBL] [Abstract][Full Text] [Related]
10. Folding and membrane insertion of amyloid-beta (25-35) peptide and its mutants: implications for aggregation and neurotoxicity. Tsai HH; Lee JB; Tseng SS; Pan XA; Shih YC Proteins; 2010 Jun; 78(8):1909-25. PubMed ID: 20229606 [TBL] [Abstract][Full Text] [Related]
11. Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study. Lam AR; Teplow DB; Stanley HE; Urbanc B J Am Chem Soc; 2008 Dec; 130(51):17413-22. PubMed ID: 19053400 [TBL] [Abstract][Full Text] [Related]
12. Interaction of Alzheimer's A beta peptide with an engineered binding protein--thermodynamics and kinetics of coupled folding-binding. Hoyer W; Härd T J Mol Biol; 2008 Apr; 378(2):398-411. PubMed ID: 18358490 [TBL] [Abstract][Full Text] [Related]
13. The Arctic mutation accelerates Aβ aggregation in SDS through reducing the helical propensity of residues 15-25. Lo CJ; Wang CC; Huang HB; Chang CF; Shiao MS; Chen YC; Lin TH Amyloid; 2015 Mar; 22(1):8-18. PubMed ID: 25376379 [TBL] [Abstract][Full Text] [Related]
14. Specific binding of a β-cyclodextrin dimer to the amyloid β peptide modulates the peptide aggregation process. Wahlström A; Cukalevski R; Danielsson J; Jarvet J; Onagi H; Rebek J; Linse S; Gräslund A Biochemistry; 2012 May; 51(21):4280-9. PubMed ID: 22554145 [TBL] [Abstract][Full Text] [Related]
15. Expression and purification of a recombinant peptide from the Alzheimer's beta-amyloid protein for solid-state NMR. Sharpe S; Yau WM; Tycko R Protein Expr Purif; 2005 Jul; 42(1):200-10. PubMed ID: 15939307 [TBL] [Abstract][Full Text] [Related]
16. Production and Use of Recombinant Aβ for Aggregation Studies. O'Malley TT; Linse S; Walsh DM Methods Mol Biol; 2018; 1777():307-320. PubMed ID: 29744844 [TBL] [Abstract][Full Text] [Related]
18. Histone H1 Favors Folding and Parallel Fibrillar Aggregation of the 1-42 Amyloid-β Peptide. Roque A; Sortino R; Ventura S; Ponte I; Suau P Langmuir; 2015 Jun; 31(24):6782-90. PubMed ID: 26023729 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide. Wiesehan K; Stöhr J; Nagel-Steger L; van Groen T; Riesner D; Willbold D Protein Eng Des Sel; 2008 Apr; 21(4):241-6. PubMed ID: 18252750 [TBL] [Abstract][Full Text] [Related]
20. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation. Takahashi T; Mihara H Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]